GGrantIndex
Sort

50,496 grants matching lung cancer

Functional Networks for Persister Cell Sensitivities

$535,248
Michael T McManus · University Of California, San Francisco · R01 · FY2019 · CA

Systemic RNA Delivery to Tumors

$535,205
Jinjun Shi · Brigham And Women'S Hospital · R01 · FY2022 · CA

The NYU Women's Health Study

$535,167
Yu Chen · New York University School Of Medicine · U01 · FY2023 · CA

MEG3 deletion drives lung tumorigenesis due to environmental nickel exposure

$535,153
Max Costa · New York University School Of Medicine · R01 · FY2024 · CA

Glutaredoxin, Glutathione Metabolism and Lung Cancer

$535,116
Yvonne M.w. Janssen-Heininger · University Of Vermont & St Agric College · R01 · FY2023 · CA

Characterizing genomic risk factors of lung cancers in Native Hawaiians

$535,112
Youping Deng · University Of Hawaii At Manoa · U54 · FY2025 · HG

Recognizing the tumor ecosystem: Integrating stromal and cancer antigen signals to achieve precision recognition of solid tumors by CAR T cells

$535,075
Wendell A Lim · University Of California, San Francisco · R01 · FY2024 · CA

NEUROD1 function in SCLC fate and plasticity

$535,073
Trudy Gale Oliver · Duke University · R01 · FY2025 · CA

CANCER RISKS AMONG TEXTILE WORKERS IN CHINA

$535,023
Fred Hutchinson Cancer Research Center · R01 · FY2002 · CA

Functional roles of human pulmonary DC's in the lung draining lymph nodes

$534,989
Claudia V Jakubzick · Dartmouth College · R01 · FY2020 · HL

Credentialing next-generation human glioma models for precision therapeutics

$534,956
Christopher Ryan Miller · University Of Alabama At Birmingham · R01 · FY2024 · CA

Recombinant Interleukin-33 Immunotherapy for Pancreatic Cancer

$534,914
Vinod P Balachandran · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA

OCG Data Coordinating Center

$534,849
Leonard Freedmand · Leidos Biomedical Research, Inc. · N01 · FY2019 · CA

Immunologic Monitoring and Cellular Products Laboratory

$534,844
Lisa Helene Butterfield · University Of Pittsburgh At Pittsburgh · P30 · FY2016 · CA

A FAP-Activated Proteasome Inhibitor for Killing Solid Tumors

$534,844
Barry Jones · Arisaph Pharmaceuticals, Inc. · R42 · FY2014 · CA

Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer

$534,763
University Of Colorado Denver · M01 · FY2004 · RR

Immunomodulating Ruthenium Metal Complexes for Melanoma PhotodynamicTherapy

$534,709
Sherri McFarland · University Of Texas Arlington · R01 · FY2020 · CA

Tumor Microenvironment in Cancer Progression

$534,706
Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

TCR signaling and cell cycle regulation in tumor-specific CD8 T cell dysfunction

$534,677
Mary Philip · Vanderbilt University Medical Center · R37 · FY2023 · CA

GMP Cell Therapy and Vector Core

$534,631
Adrian Philip Gee · University Of Tx Md Anderson Can Ctr · P01 · FY2012 · CA

REGULATION OF MUCOUS CELL METAPLASIA IN ASTHMA

$534,600
Yohannes Tesfaigzi · Lovelace Biomedical & Environmental Research Institute · R01 · FY2012 · HL

NOT-CA-24-111 Improving Strategies for Cancer Reduction through Early-detection and ENgagement (I-SCREEN)

$534,586
Linda S Cook · University Of Colorado Denver · UG1 · FY2025 · CA

(PQ10) The impact of the gut microbiome on the anti-tumor effects of radiotherapy

$534,585
Andrea Facciabene · University Of Pennsylvania · R01 · FY2019 · CA

Retrospective NCI Phantom-Monte Carlo Dosimetry for Late Effects in Wilms Tumor

$534,554
John Andrew Kalapurakal · Northwestern University At Chicago · R01 · FY2019 · CA

Integrated 3D Xray and Dynamic Tomographic Optical Breast Imaging System

$534,521
David A Boas · Massachusetts General Hospital · R01 · FY2011 · CA